F/M Emr Life Sciences in ETFLFSCETF
13F holders, Q3 2025 (September 30)3holders
1new positions
1sold out
$29.74avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding F/M Emr Life Sciences in ETF (LFSC) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were Emerald Mutual Fund Advisers Trust ($59.4M), Hunter Associates Investment Management LLC ($1.2M) and Advisory Services Network, LLC ($3K).
- Company
- F/M Emr Life Sciences in ETF
- Filed as
- RBB FD INC (Q3 2025)
- CUSIP
- 74933W221
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 1 | $21K |
All 13F filers, Q2 2025 → Q3 2025: 100 shares bought and 997 shares sold, net −897 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Emerald Mutual Fund Advisers Trust | 3.07% | No change | 1,997,035 | $59.4M |
| Hunter Associates Investment Management LLC | 0.17% | Reduce -0.3% | 40,596 | $1.2M |
| Advisory Services Network, LLC | 0.00% | New | 100 | $3K |
"% of holder's portfolio" is LFSC's weight in each manager's 13F, not the share of F/M Emr Life Sciences in ETF the manager owns.